ASCE+ SRLV
Human-derived exosome for visible skin rejuvenation, pore appearance, dullness, and firmness support.
Human-derived exosome formulation investigated for pigmentation and uneven skin tone support in professional aesthetic settings. Positioned for practitioners addressing melanin-related skin concerns within exosome skin booster workflows. Emerging evidence only — professional use by qualified clinicians.
EXO MELA is a human-derived exosome formulation specifically positioned within the pigmentation and uneven skin tone segment of the Korean professional aesthetic market. It represents a targeted approach to using exosome cellular signalling in contexts where practitioners are addressing melanin-related visible skin concerns.
The MELA designation indicates the product's primary focus: interactions with melanogenesis-related pathways — the biological processes governing skin pigment production and distribution. Research into exosome signalling and melanocyte biology is at a very early stage; EXO MELA is positioned based on emerging research directions rather than established clinical evidence.
In professional aesthetic practice, EXO MELA is used as part of multi-step protocols targeting visible pigmentation and uneven skin tone — typically in combination with laser treatments, chemical peels, or other tone-management modalities where the clinician is building a comprehensive programme.
Important Regulatory Notice: EXO MELA does not treat, cure, or prevent any skin condition including melasma, post-inflammatory hyperpigmentation, or other pigmentation disorders. It is a professional aesthetic product — not a pharmaceutical — and has not received FDA or equivalent drug approval. Evidence for exosomes in melanogenesis contexts is preliminary and evolving. For professional use by qualified clinicians only.
EXO MELA's exosome payload is selected and positioned with reference to emerging research into exosome signalling and melanocyte biology — a niche and early-stage but scientifically interesting area of investigation.
Positioned for visible skin tone evenness and brightening support within professional aesthetic protocols — addressing the visible appearance of melanin-related concerns, not as a medical treatment for pigmentation disorders.
Most frequently used as part of multi-step combination protocols with laser, IPL, or chemical peel treatments — where the exosome preparation supports the overall skin quality component of the programme.
Produced from human stem cell conditioned media — carrying a growth factor and signalling protein profile consistent with the broader human-derived exosome product category.
The interaction between extracellular vesicles — including exosomes — and melanocyte biology is a subject of growing scientific interest. The following reflects the research landscape, not established clinical conclusions.
Preclinical studies have begun to explore how extracellular vesicles — including those from keratinocytes — communicate with melanocytes and influence melanogenesis pathways. This cross-talk biology is an active area of basic science research without established clinical translation.
In clinical practice, exosome products are sometimes incorporated into post-laser skin quality programmes. The specific contribution of an exosome product to melanin-related concerns in such protocols has not been evaluated in controlled clinical trials.
Of all exosome skin product categories, melanogenesis-targeting is at the earliest evidence stage. Practitioners should approach EXO MELA with full awareness that its pigmentation-context positioning reflects emerging research interest — not established efficacy data.
Claims around pigmentation treatment are among the most closely scrutinised in cosmetic and aesthetic regulation globally. EXO MELA must not be described as a treatment for any diagnosed pigmentation condition. All positioning must remain within supportive, aesthetic quality language.
Transparency Statement: EXO MELA is positioned based on emerging research into exosome-melanocyte biology and the practical context of its use in professional tone-management protocols. The evidence base is at an early stage. Review our full Science & Evidence overview →
Human-derived exosome for visible skin rejuvenation, pore appearance, dullness, and firmness support.
Human-derived exosome concentrate for skin hydration, texture, radiance, and elasticity.
Plant-based exosome for luminosity and tone evenness — a complementary approach in tone management programmes.
Available exclusively through verified professional clinics and wholesale partners. Request pricing, technical data, and clinical protocol support.